Therefore, certain immune-inflammatory indicators, such as C-reactive protein (CRP) (35), platelet-lymphocyte ratio (PLR) (36), neutrophil-lymphocyte ratio (NLR) (37), lymphocyte-monocyte ratio (LMR) (38), albumin (39), and plasma fibrinogen levels (40), have been reported as potential biomarkers for diagnosing and predicting the prognosis of tumor patients. Here, ALB is linked to neoplasm.